vomiting
Midatech launch treatment to reduce chemo-induced vomiting in the US
April 11, 2016Research and Development, Sales and Marketing chemotherapy, midatech, nausea, oncology, radiation, vomiting
Midatech Pharma (NASDAQ: MTP) has the full commercial launch of Zuplenz (ondansetron) in the US. The drug is an oral …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
Highlighting the value of lab research for healthcare innovation
November 2, 2026
